vs
Healthpeak Properties（DOC）与GRANITE CONSTRUCTION INC（GVA）财务数据对比。点击上方公司名可切换其他公司
GRANITE CONSTRUCTION INC的季度营收约是Healthpeak Properties的1.3倍（$912.5M vs $702.9M），Healthpeak Properties净利率更高（51.6% vs -4.0%，领先55.6%），GRANITE CONSTRUCTION INC同比增速更快（30.4% vs -6.6%），过去两年Healthpeak Properties的营收复合增速更高（0.5% vs -8.2%）
Healthpeak Properties是美国医疗地产领域的房地产投资信托基金，核心投资范畴覆盖老年住宅、生命科学相关物业及医疗办公楼三类资产。公司2007年于马里兰州组建，总部设在科罗拉多州丹佛市，在尔湾、纳什维尔、旧金山均设有办事处，截至2019年12月31日共持有617处物业的权益。
Granite Construction Inc.是美国民用建筑企业及建筑骨料生产商，为标普600指数成分股，创始地及总部位于加利福尼亚州沃森维尔，是Granite Construction Company的母公司。公司主营重型民用建筑承包与建筑骨料生产，在美国西部多州持有或租赁采石场，主要开采砂、砾石、碎石等产品。
DOC vs GVA — 直观对比
营收规模更大
GVA
是对方的1.3倍
$702.9M
营收增速更快
GVA
高出37.1%
-6.6%
净利率更高
DOC
高出55.6%
-4.0%
两年增速更快
DOC
近两年复合增速
-8.2%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $702.9M | $912.5M |
| 净利润 | $363.0M | $-36.4M |
| 毛利率 | — | 11.2% |
| 营业利润率 | 0.7% | — |
| 净利率 | 51.6% | -4.0% |
| 营收同比 | -6.6% | 30.4% |
| 净利润同比 | 28.3% | -23.9% |
| 每股收益（稀释后） | $0.28 | $-0.96 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DOCGVA
| Q1 26 | $702.9M | $912.5M | ||
| Q4 25 | $719.4M | $1.2B | ||
| Q3 25 | $705.9M | $1.4B | ||
| Q2 25 | $694.3M | $1.1B | ||
| Q1 25 | $702.9M | $699.5M | ||
| Q4 24 | $698.0M | $977.3M | ||
| Q3 24 | $700.4M | $1.3B | ||
| Q2 24 | $695.5M | $1.1B |
净利润DOCGVA
| Q1 26 | $363.0M | $-36.4M | ||
| Q4 25 | $114.0M | $52.0M | ||
| Q3 25 | $-117.1M | $102.9M | ||
| Q2 25 | $31.7M | $71.7M | ||
| Q1 25 | $42.8M | $-33.7M | ||
| Q4 24 | $4.5M | $41.5M | ||
| Q3 24 | $85.9M | $79.0M | ||
| Q2 24 | $146.0M | $36.9M |
毛利率DOCGVA
| Q1 26 | — | 11.2% | ||
| Q4 25 | — | 14.4% | ||
| Q3 25 | 58.6% | 18.2% | ||
| Q2 25 | 60.2% | 17.7% | ||
| Q1 25 | 61.1% | 12.0% | ||
| Q4 24 | 60.3% | 15.4% | ||
| Q3 24 | 60.0% | 15.9% | ||
| Q2 24 | 60.6% | 15.2% |
营业利润率DOCGVA
| Q1 26 | 0.7% | — | ||
| Q4 25 | 17.4% | 6.4% | ||
| Q3 25 | 9.2% | 10.0% | ||
| Q2 25 | 5.7% | 9.2% | ||
| Q1 25 | 7.7% | -5.7% | ||
| Q4 24 | -2.2% | 6.2% | ||
| Q3 24 | 14.1% | 8.2% | ||
| Q2 24 | 22.3% | 7.9% |
净利率DOCGVA
| Q1 26 | 51.6% | -4.0% | ||
| Q4 25 | 73.2% | 4.5% | ||
| Q3 25 | -16.6% | 7.2% | ||
| Q2 25 | 4.6% | 6.4% | ||
| Q1 25 | 6.1% | -4.8% | ||
| Q4 24 | 0.7% | 4.2% | ||
| Q3 24 | 12.3% | 6.2% | ||
| Q2 24 | 21.0% | 3.4% |
每股收益（稀释后）DOCGVA
| Q1 26 | $0.28 | $-0.96 | ||
| Q4 25 | $0.16 | $1.23 | ||
| Q3 25 | $-0.17 | $1.98 | ||
| Q2 25 | $0.05 | $1.42 | ||
| Q1 25 | $0.06 | $-0.77 | ||
| Q4 24 | $0.02 | $0.99 | ||
| Q3 24 | $0.12 | $1.57 | ||
| Q2 24 | $0.21 | $0.76 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $-1.2B | $265.7M |
| 总债务越低越好 | — | $1.2B |
| 股东权益账面价值 | $7.8B | $1.1B |
| 总资产 | $21.6B | $3.8B |
| 负债/权益比越低杠杆越低 | — | 1.15× |
8季度趋势，按日历期对齐
现金及短期投资DOCGVA
| Q1 26 | $-1.2B | $265.7M | ||
| Q4 25 | $467.5M | $600.2M | ||
| Q3 25 | $91.0M | $547.2M | ||
| Q2 25 | $89.4M | $385.3M | ||
| Q1 25 | $70.6M | $422.8M | ||
| Q4 24 | $119.8M | $585.6M | ||
| Q3 24 | $180.4M | $472.4M | ||
| Q2 24 | $106.9M | $377.2M |
总债务DOCGVA
| Q1 26 | — | $1.2B | ||
| Q4 25 | $9.8B | $1.3B | ||
| Q3 25 | $9.1B | $1.3B | ||
| Q2 25 | $9.0B | $740.4M | ||
| Q1 25 | $8.9B | $739.7M | ||
| Q4 24 | $8.7B | $739.0M | ||
| Q3 24 | $8.6B | $738.6M | ||
| Q2 24 | $8.6B | $738.9M |
股东权益DOCGVA
| Q1 26 | $7.8B | $1.1B | ||
| Q4 25 | $7.5B | $1.2B | ||
| Q3 25 | $7.6B | $1.2B | ||
| Q2 25 | $7.9B | $1.1B | ||
| Q1 25 | $8.2B | $993.5M | ||
| Q4 24 | $8.4B | $1.0B | ||
| Q3 24 | $8.6B | $1.0B | ||
| Q2 24 | $8.8B | $931.7M |
总资产DOCGVA
| Q1 26 | $21.6B | $3.8B | ||
| Q4 25 | $20.3B | $4.0B | ||
| Q3 25 | $19.6B | $4.1B | ||
| Q2 25 | $19.8B | $3.1B | ||
| Q1 25 | $19.8B | $2.9B | ||
| Q4 24 | $19.9B | $3.0B | ||
| Q3 24 | $20.0B | $3.1B | ||
| Q2 24 | $20.2B | $2.9B |
负债/权益比DOCGVA
| Q1 26 | — | 1.15× | ||
| Q4 25 | 1.31× | 1.14× | ||
| Q3 25 | 1.20× | 1.16× | ||
| Q2 25 | 1.14× | 0.70× | ||
| Q1 25 | 1.08× | 0.74× | ||
| Q4 24 | 1.04× | 0.73× | ||
| Q3 24 | 1.00× | 0.73× | ||
| Q2 24 | 0.98× | 0.79× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DOC
| Outpatient Medical | $320.5M | 46% |
| Lab | $217.6M | 31% |
| Senior Housing | $148.9M | 21% |
| Other | $14.3M | 2% |
| Corporate Non-segment | $1.5M | 0% |
GVA
暂无分部数据
